HOLD
₹729
₹682.4
₹645
11.52%
Motilal Oswal Financial Services’ August 13, 2026 results update indicates that an earnings recovery is under way at Bata India, although a sustained acceleration in topline growth remains essential. The broker reiterates its Neutral rating as operating initiatives gain traction, while revenue growth and margin recovery are expected to be gradual.
Motilal Oswal expects profitability to remain below pre-COVID levels even by FY28E. However, a demand recovery in organised value footwear following GST rationalisation could provide downside support. The broker’s Rs 645 target price is based on 30 times September 2028E EPS of Rs 22, implying 12 per cent downside from the report CMP of Rs 729.
Bata India reported 1QFY27 revenue of Rs 9,789 million, up 4 per cent year on year and broadly in line with Motilal Oswal’s estimate. Growth reflected premiumisation, volume growth and consumer engagement across channels.
| Metric | 1QFY27 | Year-on-year change | Versus estimate |
|---|---|---|---|
| Revenue | Rs 9,789 million | Up 4 per cent | Broadly in line |
| Gross profit | Rs 5,360 million | Up 6 per cent | — |
| Gross margin | 54.8 per cent | Expanded 127 basis points | 160 basis points above estimate |
| EBITDA | Rs 2,040 million | Up 3 per cent | 4 per cent below estimate |
| EBITDA margin | 20.8 per cent | Declined 27 basis points | — |
| Adjusted PAT | Rs 640 million | Up 13 per cent | 15 per cent above estimate |
Gross-margin expansion was supported by higher full-price sales and lower markdowns despite continued raw-material pressure. On an underlying basis, after adjusting for channel mix, gross-margin improvement was about 230 basis points.
Employee costs declined 2 per cent year on year, while selling, general and administrative expenses rose 16 per cent, mainly due to a roughly 25 per cent increase in advertising expenditure. Higher brand investment offset gross-margin gains, resulting in a decline in EBITDA margin. Lower depreciation and finance costs supported adjusted PAT growth. Reported one-offs of Rs 51 million included foreign-exchange and ERP implementation costs, while underlying PBT increased 23 per cent year on year.
Management indicated that redesigned products are entering stores and will see a broader rollout over the next few quarters. The product proposition focuses on design authority, comfort, technology and premiumisation, with the potential to increase average selling prices and gross margins.
ZBM has reached 775 COCO stores, representing about 80 per cent of retail revenue. These stores are delivering mid-single-digit higher growth than the remainder of the network. ZBM 2.0, or Project Elevate, is intended to generate further gains in assortment and merchandising productivity.
Franchise expansion remains a key growth lever. Bata India has 750 franchise stores, sustained high-single-digit like-for-like growth and partner return on investment of about 18–24 per cent. Management has identified more than 600 potential new trade areas. Motilal Oswal considers the franchise format more EBIT-accretive than COCO stores.
Inventory availability has improved about 12 per cent, while store lines have reduced to 68 per cent of the level two years earlier. Further assortment rationalisation towards about 60 per cent should reduce markdowns and improve full-price sell-through.
Manufacturing consolidation has reduced Bata India’s vendor base to about 70 from 100–120, with a target of about 30 vendors over the next three to five years. Management targets about 200 basis points of savings through lower kit, mould and material complexity.
Voluntary retirement schemes and technology-led organisation redesign are also improving employee-cost efficiency. Marketing spend has increased to about 3–3.5 per cent of sales from about 2.5 per cent earlier and is expected to remain elevated for several quarters to support the new product cycle.
Motilal Oswal forecasts FY26–28E revenue, pre-IND AS EBITDA and adjusted PAT CAGR of 6 per cent, 13 per cent and 21 per cent, respectively, from a low base.
| Estimate revision | Change |
|---|---|
| FY27E revenue | Reduced by 1.4 per cent |
| FY27E pre-IND AS EBITDA | Reduced by 5.2 per cent |
| FY28E pre-IND AS EBITDA | Reduced by 9.1 per cent |
Key thesis risks include:
Disclaimer: This is a summary of a research report published by the broker/research house identified above. The views, recommendations, target prices and estimates are those of the respective broker and do not represent DSIJ investment advice. The summary may be AI-assisted, hence please refer to the original report for complete details, disclosures and risks.
Copyright 2026 by DSIJ Wealth Advisory Pvt. Ltd. (Formerly Known as DSIJ Pvt. Ltd.)